Given the increasing recognition and implications of the pathophysiological consequences of hyperleptinemia, further research is warranted to elucidate the role of leptin in OSA pathogenesis, leptin-mediated comorbidities in OSA and its potential value as a biomarker of metabolic risk and treatment efficacy. Here, LEP is linked to obstructive sleep apnea syndrome.